EUVIMEDEUVIMED entdecken
Open Access

Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy

Yu-Jia Chen iD, Guan-Nan Li iD, Xian-Jing Li iD, Lin-Xing Wei, Min-Jie Fu iD, Zhou-Li Cheng, Zhen Yang iD, Gui-Qi Zhu iD, Xu-Dong Wang, Cheng Zhang iD, Jin-Ye Zhang, Yi-Ping Sun und 9 weitere

Science Advances · 28.04.2023 · 9 (17)

DOI: 10.1126/sciadv.adg0654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 28.04.2023. Verfasst von Yu-Jia Chen und 20 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital, Fudan University; Shanghai Key Laboratory of Medical Epigenetics, Internati…. Hauptthemen laut MEDLINE: Tumor-Associated Macrophages, Neoplasms. Die Arbeit wurde bisher 126-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune-responsive gene 1 (IRG1) encodes aconitate decarboxylase (ACOD1) that catalyzes the production of itaconic acids (ITAs). The anti-inflammatory function of IRG1/ITA has been established in multiple pathogen models, but very little is known in cancer. Here, we show that IRG1 is expressed in tumor-associated macrophages (TAMs) in both human and mouse tumors. Mechanistically, tumor cells induce Irg1 expression in macrophages by activating NF-κB pathway, and ITA produced by ACOD1 inhibits TET DNA dioxygenases to dampen the expression of inflammatory genes and the infiltration of CD8 + T cells into tumor sites. Deletion of Irg1 in mice suppresses the growth of multiple tumor types and enhances the efficacy of anti–PD-(L)1 immunotherapy. Our study provides a proof of concept that ACOD1 is a potential target for immune-oncology drugs and IRG1 -deficient macrophages represent a potent cell therapy strategy for cancer treatment even in pancreatic tumors that are resistant to T cell–based immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor-Associated MacrophagesNeoplasmsHumansAnimalsMiceCD8-Positive T-LymphocytesMacrophagesImmunotherapyHydro-Lyases

Substanzen

Acod1 protein, mouseHydro-Lyases

Autor:innen und Institutionen

  • Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital, Fudan University; Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism (Ministry of…
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, China.
  • Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
  • Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of the Ministry of Education, Shanghai, China.
  • Center for Stem Cell and Regenerative Medicine, Department of Basic Medical Sciences, and Bone Marrow for Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310058,…
  • State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200433, China.

ORCID-Profile: Yu-Jia Chen, Guan-Nan Li, Xian-Jing Li, Min-Jie Fu, Zhen Yang, Gui-Qi Zhu, Cheng Zhang, Hexige Saiyin, Jin Zhang, Wen-Wei Zhu, Kun-Liang Guan, Yue Xiong, Yong Yang, Dan Ye, Lei-Lei Chen

Zitieren

APA

Chen, Y. J., Li, G. N., Li, X. J., Wei, L. X., Fu, M. J., Cheng, Z. L., Yang, Z., Zhu, G. Q., Wang, X. D., Zhang, C., Zhang, J. Y., Sun, Y. P., Saiyin, H., Zhang, J., Liu, W. R., Zhu, W. W., Guan, K. L., Xiong, Y., Yang, Y., …, & Chen, L. L. (2023). Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy. Science Advances, 9(17). https://doi.org/10.1126/sciadv.adg0654

Vancouver

Chen YJ, Li GN, Li XJ, Wei LX, Fu MJ, Cheng ZL, et al. Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy. Science Advances. 2023;9(17). doi:10.1126/sciadv.adg0654

BibTeX
@article{Chen2023,
  author = {Chen, Yu-Jia and Li, Guan-Nan and Li, Xian-Jing and Wei, Lin-Xing and Fu, Min-Jie and Cheng, Zhou-Li and Yang, Zhen and Zhu, Gui-Qi and Wang, Xu-Dong and Zhang, Cheng and Zhang, Jin-Ye and Sun, Yi-Ping and Saiyin, Hexige and Zhang, Jin and Liu, Wei-Ren and Zhu, Wen-Wei and Guan, Kun-Liang and Xiong, Yue and Yang, Yong and Ye, Dan and Chen, Lei-Lei},
  title = {Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {17},
  doi = {10.1126/sciadv.adg0654}
}
Kostenlos starten →